Test Catalog

Test ID: BLAST    
Blastomyces Antibody, Enzyme Immunoassay, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Aiding in the diagnosis of blastomycosis

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

If result is equivocal or positive, SBL / Blastomyces Antibody by Immunodiffusion, Serum will be ordered at an additional charge.


See Meningitis/Encephalitis Panel Algorithm in Special Instructions.

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

Blastomyces dermatitidis, an adimorphic fungus, is endemic throughout the midwestern, south-central, and southeastern Unites States, particularly in regions around the Ohio and Mississippi river valley, the Great Lakes and the Saint Lawrence River. It is also found in regions of Canada. Blastomyces is an environmental fungus, preferring moist soil and decomposing organic matter, which produces fungal spores that are released and inhaled by animals or humans. At body temperature, the spores mature into yeast which can stay in the lungs or disseminated through the bloodstream to other parts of the body. Recently, through phylogenetic analysis, B. dermatitidis has been separated into two distinct species-B. dermatitidis and Blastomyces gilchristii, both able to cause blastomycosis in infected patients. Interestingly, B. dermatitidis infections are associated more frequently with dissemination, particularly in elderly patients, smokers and immunocompromised hosts, while B. gilchristii has primarily been associated with pulmonary and constitutional symptoms.


Approximately 50% of patients infected with Blastomyces will develop symptoms, which are frequently non-specific, including fever, cough, night sweats, myalgia or arthralgia, weight loss, chest pain and fatigue. Typically symptoms appear anywhere from 3 weeks to 3 months following infection.


Diagnosis of blastomycosis relies on a combination of assays, including culture and molecular testing on appropriate specimens and serologic evaluation for both antibodies to and antigen released from Blastomyces. Although culture remains the gold standard method and is highly specific, the organism can take several days to weeks to grow and sensitivity is diminished in cases of acute or localized disease. Similarly, molecular testing offers high specificity and a rapid turnaround time, however sensitivity is imperfect. Detection of an antibody response to Blastomyces offers high specificity, however results may be falsely negative in acutely infected patients and in immunosuppressed patients.

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.


Reference values apply to all ages.

Interpretation Provides information to assist in interpretation of the test results

A positive result indicates that IgG and/or IgM antibodies to Blastomyces were detected. The presence of antibodies is presumptive evidence that the patient was or is currently infected with (or was exposed to) Blastomyces.


A negative result indicates that antibodies to Blastomyces were not detected. The absence of antibodies is presumptive evidence that the patient was not infected with Blastomyces. However, the specimen may have been obtained before antibodies were detectable or the patient may be immunosuppressed. If infection is suspected, another specimen should be drawn 7 to 14 days later and submitted for testing.


Specimens testing positive or equivocal will be submitted for further testing by another conventional serologic test (eg, SBL / Blastomyces Antibody by Immunodiffusion, Serum).

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

A negative result does not rule-out blastomycosis.


Cross-reactivity may occur with other fungal infections such as Aspergillus, Coccidioides, or Histoplasma.

Clinical Reference Recommendations for in-depth reading of a clinical nature

Kaufman L, Kovacs JA, Reiss E: Clinical immunomycology. In Manual of Clinical and Laboratory Immunology. Edited by NR Rose, EC De Macario, JD Folds, et al. Washington DC, ASM Press, 1997, pp 588-589

Special Instructions Library of PDFs including pertinent information and forms related to the test